John Maraganore πŸ‡ΊπŸ‡ΈπŸ‡¬πŸ‡·πŸ‡ΊπŸ‡¦ (@JMaraganore) header
John Maraganore πŸ‡ΊπŸ‡ΈπŸ‡¬πŸ‡·πŸ‡ΊπŸ‡¦ (@JMaraganore) profile picture

Founding CEO of @Alnylam. Pioneered RNAi therapeutics as a whole new class of medicines for patients. Now bioentrepreneur-at-large. Opinions are my own.

Boston, MA
Joined June 2017
Photo by John Maraganore πŸ‡ΊπŸ‡ΈπŸ‡¬πŸ‡·πŸ‡ΊπŸ‡¦ (@JMaraganore)Photo by John Maraganore πŸ‡ΊπŸ‡ΈπŸ‡¬πŸ‡·πŸ‡ΊπŸ‡¦ (@JMaraganore)Photo by John Maraganore πŸ‡ΊπŸ‡ΈπŸ‡¬πŸ‡·πŸ‡ΊπŸ‡¦ (@JMaraganore)Photo by John Maraganore πŸ‡ΊπŸ‡ΈπŸ‡¬πŸ‡·πŸ‡ΊπŸ‡¦ (@JMaraganore)Photo by John Maraganore πŸ‡ΊπŸ‡ΈπŸ‡¬πŸ‡·πŸ‡ΊπŸ‡¦ (@JMaraganore)Photo by John Maraganore πŸ‡ΊπŸ‡ΈπŸ‡¬πŸ‡·πŸ‡ΊπŸ‡¦ (@JMaraganore)Photo by John Maraganore πŸ‡ΊπŸ‡ΈπŸ‡¬πŸ‡·πŸ‡ΊπŸ‡¦ (@JMaraganore)Photo by John Maraganore πŸ‡ΊπŸ‡ΈπŸ‡¬πŸ‡·πŸ‡ΊπŸ‡¦ (@JMaraganore)Photo by John Maraganore πŸ‡ΊπŸ‡ΈπŸ‡¬πŸ‡·πŸ‡ΊπŸ‡¦ (@JMaraganore)Photo by John Maraganore πŸ‡ΊπŸ‡ΈπŸ‡¬πŸ‡·πŸ‡ΊπŸ‡¦ (@JMaraganore)
John Maraganore πŸ‡ΊπŸ‡ΈπŸ‡¬πŸ‡·πŸ‡ΊπŸ‡¦ retweeted
George Whitesides was a towering figure in science. A pioneer in bringing materials science, chemistry, and biology together. A patriot, who helped our nation. And overall, just a nice guy, who was willing to build some companies with a young venture capitalist who mostly didn’t know much. RIP
Last night my father George McClelland Whitesides passed away. He was at home and surrounded by family, and his young granddaughters had just said good night to him.Β  He was a brilliant scientist, teacher, and entrepreneur. An advocate for basic research, he also believed that science and technology should serve society. He lived a great, full life, married to his wife Barbara for 57 years.Β  Their two sons had 5 grandchildren, who gave him much joy in his later years. We'll share more details with friends and colleagues for a rememberance once finalized.
5
9
1
109
7,395
So so sad, but such a great life! R.I.P. George!
Last night my father George McClelland Whitesides passed away. He was at home and surrounded by family, and his young granddaughters had just said good night to him.Β  He was a brilliant scientist, teacher, and entrepreneur. An advocate for basic research, he also believed that science and technology should serve society. He lived a great, full life, married to his wife Barbara for 57 years.Β  Their two sons had 5 grandchildren, who gave him much joy in his later years. We'll share more details with friends and colleagues for a rememberance once finalized.
1
14
2,306
Hilarious!
I have sadly betrayed the puffy vest community... This post made me laugh out loud... well done to "Chad Whitlow, Founder and CEO, Vestibule AI" I'm zipping my vest up right now. inpreparation.substack.com/p…
4
2,495
John Maraganore πŸ‡ΊπŸ‡ΈπŸ‡¬πŸ‡·πŸ‡ΊπŸ‡¦ retweeted
Will payers reimburse one-time therapies? Will patients choose them? Are β€œcures” and prevention a good business? Or should we stick to chronic medications? Can one-time gene therapies be commercially successful? I hear these questions often from investors and media
10
7
3
62
5,205
John Maraganore πŸ‡ΊπŸ‡ΈπŸ‡¬πŸ‡·πŸ‡ΊπŸ‡¦ retweeted
a world where peace only comes through strength is a world serving those who have little other than strength to project. that’s a world more suited for china and russia. a world where common values, rule of law and shared institutions also matter is ultimately to the advance of the united states and its allies. not to mention those of us common folk who live there.
Peace through strength.
79
128
10
799
49,262
Probably would have helped… but it did require some human judgement.
Incredible. In this case, do you think AI would’ve made better decisions than big pharma?
2
6
1,955
Like all drugs, LIVSAYIS (cemdisiran or β€œCemdi”) had an interesting history… - the program started in 2011 as one of the original β€œAlnylam 5x15” programs - it was discovered/championed by @Alnylam scientist Anna Borodovsky - the program faced a large number of uncertainties… most notably, would a 98-99% silencing of C5 be sufficient or was 99.9999% required? - also, with all the potential complement-mediated disease indications to pursue, which to go after first and with what sequence? - we started with Paroxysmal Nocturnal Hemoglobinuria (PNH) due to precedence with anti-C5 Mab eculizumab from Alexion - Alexion CEO Lenny Bell would actively tell Wall Street that the drug wouldn’t work. Future CEO David Hallal pushed back also. - the drug failed to show convincing efficacy despite 98-99% C5 silencing… many people felt the program was dead and would never succeed. Lenny and David were right! So were other internal skeptics like head of R&D Akshay Vaishnaw. - our project team, led by Project Leader Jeff Miller and Project Manager Nori Kawahata and clinician Jae Kim, made the case to evaluate Cemdi in settings without somatic mutations in the complement regulatory pathway, like PNH - we prioritized IgA nephropathy and myasthenia gravis. Cemdi showed very encouraging data in IgAN, but was it competitive vs. emerging anti-APRIL and related approaches? - in 2019, we rolled it into the Regeneron partnership, with the goal of adding it to their anti-C5 Mab pozelimab - Regeneron launched a series of pivotal studies including one with Cemdi as monotherapy in gMG, with positive results reported in 2025 (I’ll never forget the call I got from George while on the beach in Nantucket) And now, LIVSAYIS becomes an approved medicine, and the FIRST RNAi therapeutic for autoimmune disease!
AMAZING! Behold the 9th RNAi Therapeutic ever approved! LIVSAYIS (aka, cemdisiran)!!! Discovered at @Alnylam and developed by @Regeneron! The first approval in a remarkable collaboration we forged in 2019. Great news for patients with gMG!
5
4
2
86
8,591
AMAZING! Behold the 9th RNAi Therapeutic ever approved! LIVSAYIS (aka, cemdisiran)!!! Discovered at @Alnylam and developed by @Regeneron! The first approval in a remarkable collaboration we forged in 2019. Great news for patients with gMG!
The U.S. FDA has approved our medicine as the first and only siRNA therapy in generalized myasthenia gravis (#gMG), which offers a new approach for people living with this debilitating, often unpredictable disease. Β  Read more: bit.ly/491nvl7
3
13
2
104
13,301
John Maraganore πŸ‡ΊπŸ‡ΈπŸ‡¬πŸ‡·πŸ‡ΊπŸ‡¦ retweeted
Most American parents have never seen a child with measles Sadly, that is changing Today the US lost its measles elimination status It's the canary in the coal mine for deeper problems in our public health system I'll be on @NPR All Things Considered later to discuss
32
31
2
212
10,726
πŸ’―
ROBERT F. KENNEDY JR. IS PRESIDING OVER A PUBLIC HEALTH DISASTER. AMERICA MUST ACT. Today's Reuters investigation into America's measles resurgence indicts Health Secretary Robert F. Kennedy Jr. More than 7,700 Americans have contracted measles since 2025. Thirteen have died. Childhood vaccination rates are falling. After 26 years, America has lost its measles-elimination status. This is a national disgrace. I have warned of the consequences when ideology replaces science, experts are driven out, and trust in vaccines is undermined. In May, I described measles as the canary in the coal mine. In October, I warned that dismantling the CDC could bring back diseases we had learned to control. We are now witnessing what I feared. Kennedy has spent years promoting doubts about vaccines, including claims rooted in the discredited suggestion that MMR vaccination causes autism. That claim originated in Andrew Wakefield's 1998 paper, retracted by The Lancet in 2010 and exposed as fraudulent. Yet Kennedy challenges established vaccine science while occupying America's highest public health office. Under his leadership, the CDC has suffered mass staff reductions, the loss of experienced scientific leaders and the removal of independent vaccine advisers. Public health programs have been weakened while preventable diseases spread. This is not reform. It is the destruction of capabilities that took generations to build. In Biotech in the Balance, I argued that medicine and biotechnology depend on scientific integrity, independent institutions and public trust. Kennedy's leadership violates those principles. Children should not suffer potentially fatal diseases because of a political appointee's personal convictions. And measles may be only the beginning. Tomorrow, November 18, the Senate health committee is scheduled to vote on Heidi Overton's nomination to lead the FDA. Whoever becomes Commissioner will report to Kennedy. How can that individual defend scientific independence when the Secretary repeatedly challenges established medical science? I cannot believe President Trump intended this outcome. Nor can I imagine any responsible American, Republican or Democrat, would want it. But the evidence is impossible to ignore, and his administration has the authority and responsibility to act. Kennedy should no longer serve as Secretary of Health and Human Services. The administration must recognize the damage and restore competent scientific leadership. I call on physicians, scientists, patient advocates, biotechnology leaders and elected representatives of both parties to speak out and demand action. Silence in the face of this evidence is indefensible. We have a responsibility to protect children, prevent unnecessary deaths and defend the scientific institutions on which every American depends. I ask everyone who shares these concerns to add their voice. We must act now, before more lives are lost. #News #Biotech #Healthcare #USA #RFK #measles
6
1
9
1,642
John Maraganore πŸ‡ΊπŸ‡ΈπŸ‡¬πŸ‡·πŸ‡ΊπŸ‡¦ retweeted
New frontier for CV risk prevention Single shot per yr for LDL and BP control (two most critical casual factors for ASCVD development and progression) Paradigm shift is near addressing key barriers: pill burden, inertia, side effects, cost, scalability. πŸ‘πŸ‘πŸ‘
Very excited to advance this new frontier of medicine! By lowering LDL-C (COR-1004) and blood pressure (COR-2003) as a once annual SC injection, @corserahealth imagines a world without cardiovascular disease.
4
38
2,739
Very excited to advance this new frontier of medicine! By lowering LDL-C (COR-1004) and blood pressure (COR-2003) as a once annual SC injection, @corserahealth imagines a world without cardiovascular disease.
We’re excited to announce the initiation of our Phase 1 trial of COR-1004 and COR-2003, marking the first clinical evaluation of this dual-targeting approach for the prevention of #cardiovasculardisease. Read the full announcement: corserahealth.com/assets/pdf…
3
1
2
60
7,102
John Maraganore πŸ‡ΊπŸ‡ΈπŸ‡¬πŸ‡·πŸ‡ΊπŸ‡¦ retweeted
This is very cool: a single dose of Regeneron's CIDEB siRNA, discovered by mining human genetics, ~matches retatrutide's unprecedented reduction in liver fat in fatty liver disease, without needing to cause any weight loss. The exciting potential is in the ~10% of people who have fatty liver disease without overweight/obesity (or, of course, in combination with GLP1s).
Presented at #TLM26: A single dose of an siRNA targeting liver expression of π˜Šπ˜π˜‹π˜Œπ˜‰ was associated with a reduction in liver fat of 58 to 80% at week 36 after treatment in persons with metabolic dysfunction–associated steatotic liver disease. Full trial results: nej.md/4fcxkjE @AASLDtweets
3
33
4
184
18,505